ErgomedCompany research
Click on headlines below to download research
Solid FY22 marked by broad-based growth
Ergomed | 17/04/2023
Ergomed reported FY22 results broadly in line with our expectations. Group revenues grew 22.5% y-o-y to £145.3m, underpinned by sustained demand for…
Exiting FY22 on a strong footing
Ergomed | 21/12/2022
In the run-up to Ergomed’s FY22 trading update (expected end-January 2023), we take a fresh look at our estimates for the company and make minor…
Two key management changes
Ergomed | 18/11/2022
In a strategic move to support its business development plans and digitisation efforts, Ergomed has announced two senior appointments to its executive…
Poised for a strong FY22
Ergomed | 30/09/2022
Ergomed released full H122 accounts following its July 2022 trading update, the key takeaway of which was the sustained strong momentum across both business…